Quarterly Results

AHLCON PARENTERALS (INDIA) LTD.

NSE : NABSE : 524448ISIN CODE : INE027C01011Industry : Pharmaceuticals & DrugsHouse : Ahlcon Parenterals - MNC
BSE515.000 (0 %)
PREV CLOSE ( ) 515.00
OPEN PRICE ( ) 515.00
BID PRICE (QTY) 515.00 (2000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29501
TODAY'S LOW / HIGH ( )514.75 516.75
52 WK LOW / HIGH ( ) 514.75517.25
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
332.03
282.5
283.94
311.49
Total Expenditure
245.93
234.14
218.34
209.4
PBIDT (Excl OI)
86.1
48.36
65.6
102.09
Other Income
2.62
2.26
0.81
0.32
Operating Profit
88.72
50.62
66.41
102.41
Interest
0.65
1.12
0.52
1.93
Exceptional Items
NA
NA
NA
NA
PBDT
88.07
49.5
65.89
100.48
Depreciation
10.78
10.91
10.89
8.51
Profit Before Tax
77.29
38.59
55
91.97
Tax
11.84
10.44
16.12
31.03
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
65.45
28.15
38.88
60.94
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
65.45
28.15
38.88
60.94
Equity Capital
72
72
72
72
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
9.09
3.90
5.4
8.46
Calculated EPS (Annualised)
36.36
15.63
21.6
33.85
No of Public Share Holdings
485228
1800038
1800038
1800038
% of Public Share Holdings
6.74
25
25
25
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
25.93
17.11
23.10
32.77
PBIDTM%
26.72
17.91
23.38
32.87
PBDTM%
26.52
17.52
23.20
32.25
PBTM%
23.27
13.66
19.37
29.52
PATM%
19.71
9.96
13.69
19.56
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.